Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7269162-itraconazole drug-drug interaction study in healthy participants
NL-OMON59826Phase 1Completed
- Sponsor
- Roche
- Start
- May 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nivegacetor and itraconazole, sponsored by Roche. Primary endpoint: Primary endpoint(s). Started May 2024; status: completed.
02
Drugs
nivegacetoritraconazole
Beyond the preview
Go deeper on NL-OMON59826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59826.